Switch theme
Sign up to access all valuation multiples
EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. Its businesses are Point-of-Care, Central Laboratory, Life Sciences, and Contract Manufacturing. It caters to companies focused on areas such as diabetes, Hematology, Infectious diseases, Clinical Chemistry, Life Sciences OEM, Sports medicine, Custom Bioprocessing, and Others. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.
2002
317
LTM Revenue $65.8M
LTM EBITDA $15.0M
$108M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
EKF Diagnostics has a last 12-month revenue of $65.8M and a last 12-month EBITDA of $15.0M.
In the most recent fiscal year, EKF Diagnostics achieved revenue of $67.7M and an EBITDA of $9.9M.
EKF Diagnostics expects next 12-month revenue of XXX and NTM EBITDA of XXX
See EKF Diagnostics valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $85.8M | $67.7M | XXX | XXX | XXX |
| Gross Profit | $50.7M | $31.0M | XXX | XXX | XXX |
| Gross Margin | 59% | 46% | XXX | XXX | XXX |
| EBITDA | -$2.8M | $9.9M | XXX | XXX | XXX |
| EBITDA Margin | -3% | 15% | XXX | XXX | XXX |
| Net Profit | $20.4M | -$13.0M | XXX | XXX | XXX |
| Net Margin | 24% | -19% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, EKF Diagnostics's stock price is GBP 0 (or $0).
EKF Diagnostics has current market cap of GBP 95.7M (or $123M), and EV of GBP 84.0M (or $108M).
See EKF Diagnostics trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $108M | $123M | XXX | XXX | XXX | XXX | $0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, EKF Diagnostics has market cap of $123M and EV of $108M.
EKF Diagnostics's trades at 1.6x LTM EV/Revenue multiple, and 7.2x LTM EBITDA.
Analysts estimate EKF Diagnostics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for EKF Diagnostics and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $108M | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 10.9x | XXX | XXX | XXX |
| P/E | 40.7x | XXX | XXX | XXX |
| P/E/Growth | 0.6x | XXX | XXX | XXX |
| EV/FCF | -126.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpEKF Diagnostics's NTM/LTM revenue growth is 7%
EKF Diagnostics's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, EKF Diagnostics's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate EKF Diagnostics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for EKF Diagnostics and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -21% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -452% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 21% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 37% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
EKF Diagnostics acquired XXX companies to date.
Last acquisition by EKF Diagnostics was XXXXXXXX, XXXXX XXXXX XXXXXX . EKF Diagnostics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was EKF Diagnostics founded? | EKF Diagnostics was founded in 2002. |
| Where is EKF Diagnostics headquartered? | EKF Diagnostics is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does EKF Diagnostics have? | As of today, EKF Diagnostics has 317 employees. |
| Who is the CEO of EKF Diagnostics? | EKF Diagnostics's CEO is Mr. Gavin Joseph Jones. |
| Is EKF Diagnostics publicy listed? | Yes, EKF Diagnostics is a public company listed on LON. |
| What is the stock symbol of EKF Diagnostics? | EKF Diagnostics trades under EKF ticker. |
| When did EKF Diagnostics go public? | EKF Diagnostics went public in 2002. |
| Who are competitors of EKF Diagnostics? | Similar companies to EKF Diagnostics include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of EKF Diagnostics? | EKF Diagnostics's current market cap is $123M |
| What is the current revenue of EKF Diagnostics? | EKF Diagnostics's last 12-month revenue is $65.8M. |
| What is the current EBITDA of EKF Diagnostics? | EKF Diagnostics's last 12-month EBITDA is $15.0M. |
| What is the current EV/Revenue multiple of EKF Diagnostics? | Current revenue multiple of EKF Diagnostics is 1.6x. |
| What is the current EV/EBITDA multiple of EKF Diagnostics? | Current EBITDA multiple of EKF Diagnostics is 7.2x. |
| What is the current revenue growth of EKF Diagnostics? | EKF Diagnostics revenue growth between 2023 and 2024 was -21%. |
| Is EKF Diagnostics profitable? | Yes, EKF Diagnostics is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
